ePurines was founded by internationally recognized experts in purinergic signaling, and focuses on the development of innovative purinergic-based therapeutics for the treatment of obesity, liver and kidney diseases.

The core technologies, developed in animal models, are patented and published. Proof-of-concept established. Moving forward for development of therapeutic molecules. Pipeline technologies are also patented.